Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… NALIDIXIC ACID Tablet; 1GM NEGGRAM SANOFI SYNTHELABO | 014214 NALIDIXIC ACID Tablet; 250MG NEGGRAM SANOFI SYNTHELABO | 014214 NALIDIXIC ACID Tablet; 500MG NEGGRAM SANOFI SYNTHELABO | 071919 NALIDIXIC ACID Tablet; 1GM NALIDIXIC ACID Watson | 071936 NALIDIXIC ACID Tablet; 250MG NALIDIXIC ACID Watson 072061 NALIDIXIC ACID Tablet; 500MG NALIDIXIC ACID Watson | Nandrolone Decanoate Injection, PharmaForce, Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com